News

The 23 Best In-Office Treatments to Sculpt, Lift, and Enhance
These in-office services are not created equally. For this year’s Tools and Treatments Awards, we worked with some of our ...
Seeking Alpha8mon
Available Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to Severe Temple Hollowing - Seeking Alpha
JUVÉDERM ® VOLUMA ® XC is the One and Only Hyaluronic Acid Dermal Filler Indicated to Treat Cheeks, Chin, and Now Moderate to Severe Temple Hollowing 1,2; Only Allergan Aesthetics, the Makers ...
Yahoo Finance8mon
Available Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to Severe Temple Hollowing - Yahoo Finance
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the national availability of JUVÉDERM® VOLUMA® XC for temple hollowing. Following its U.S. FDA approval in March 2024, JUVÉDERM® VOLUMA® ...
ourculturemag1y
Juvederm: Transform Your Look with Med Supply Solutions’ Elite Products - Our Culture
A Leader in Hyaluronic Acid Fillers Recognized globally for its extensive line of hyaluronic acid dermal fillers, Juvederm, offered by Med Supply Solutions, stands at the forefront of cosmetic ...
Stockhouse1y
2024-03-05 | JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval | NYSE:ABBV | Press Release - Stockhouse
IRVINE, Calif., March 5, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of JUVÉDERM® VOLUMA® XC for injection in the ...
Nasdaq1y
Allergan Aesthetics Announces First Ever JUVÉDERM® Day
The Number One Chosen Dermal Filler Collection Celebrates with Exclusive Offers IRVINE, Calif., Aug. 1, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the ...